標(biāo)題: Titlebook: Antibody Therapy; Substitution – Immun Paul Imbach Book 2018 Springer International Publishing AG, part of Springer Nature 2018 Immunoglobu [打印本頁] 作者: Animosity 時間: 2025-3-21 19:02
書目名稱Antibody Therapy影響因子(影響力)
書目名稱Antibody Therapy影響因子(影響力)學(xué)科排名
書目名稱Antibody Therapy網(wǎng)絡(luò)公開度
書目名稱Antibody Therapy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Antibody Therapy被引頻次
書目名稱Antibody Therapy被引頻次學(xué)科排名
書目名稱Antibody Therapy年度引用
書目名稱Antibody Therapy年度引用學(xué)科排名
書目名稱Antibody Therapy讀者反饋
書目名稱Antibody Therapy讀者反饋學(xué)科排名
作者: 條街道往前推 時間: 2025-3-22 00:11
From Immune Substitution to Immuno-modulationestones in the history of human immunoglobulins since the initial observation by Ogden C. Bruton who described replacement therapy in a single boy with agammaglobulinemia. Since then, the preparations used for treatment have been markedly improved with respect to tolerability, clinical efficacy, and作者: 搬運工 時間: 2025-3-22 02:00 作者: 知識 時間: 2025-3-22 07:33 作者: 吼叫 時間: 2025-3-22 11:01
Immunomodulatory Drugs and Monoclonal Antibodies development of most such disorders, but an external trigger may be required for the eventual development of the autoimmune disease. The development of pharmacologic agents to treat such disorders by inducing self-tolerance has progressed over the last 60?years. Historically termed immunosuppressive作者: Aerate 時間: 2025-3-22 15:11 作者: 混合,攙雜 時間: 2025-3-22 20:52 作者: Expiration 時間: 2025-3-22 22:27 作者: 惡臭 時間: 2025-3-23 02:20
Essentials of the?Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentratesal use were threats for recipients (see Chap. . for additional information). “Standard IgG” preparations were the first available for clinical use. They were produced by the cold-ethanol fractionation methods and did not make an exception. Noninfectious severe AEs occurred while infectious AEs were 作者: 不溶解 時間: 2025-3-23 06:17 作者: flimsy 時間: 2025-3-23 13:21
Health-Related Quality of Life in Patients with Immune Thrombocytopenian. She was a 15-year-old girl with immune thrombocytopenia (ITP) diagnosed just over 1?year ago. Her platelet count ranged from 20 to 30?×?10./l, but she had not required any emergency department visits or had any significant bleeding events over the past 6?months. All in all she seemed stable, so m作者: 勤勉 時間: 2025-3-23 14:47 作者: Bravado 時間: 2025-3-23 19:47
The Clinical Translation of Intravenous Immunoglobulin from Substitution to Immunomodulation,y in children with ITP. Since the pathophysiology of ITP is similar to many other autoimmune or chronic inflammatory disorders, the new therapeutic phenomenon evoked worldwide clinical and laboratory research. The story is presented with citations of the first publication.作者: 諂媚于人 時間: 2025-3-24 00:35
From Immune Substitution to Immuno-modulationwed that IVIG has immunomodulatory potential offering a chance for affected children to receive effective treatment with little or no side effects compared to systemic steroids. This new principle of treatment encouraged many researchers worldwide to exploit the potential of IVIG in many other immun作者: venous-leak 時間: 2025-3-24 06:20
Mechanisms of Action and Immunomodulation by IVIgluded effects mediated through the Fab region of IgG, while others have been through the Fc region of IVIg. The presence of sugars or glycans on the Fc region have been considered by some to be important, while other work has pointed to a major role for IgG dimers or immune complexes as mediating IV作者: 誰在削木頭 時間: 2025-3-24 08:37 作者: hermetic 時間: 2025-3-24 11:41
Basics of Immunoglobulins as Effector Molecules and Drugssimilar to these of IgG, while secretory IgA antibodies are resistant to proteases and protect all mucosal surfaces. IgE is the class with the lowest plasma concentration (0.05 mcg/mL). The contact of mast cell-bound IgE with the specific antigen results in an acute inflammatory reaction that might 作者: 行業(yè) 時間: 2025-3-24 18:34
Essentials of the?Production of Safe and Efficacious State-of-the-Art Polyclonal IgG Concentratession by IgG concentrates in the early 1990s together with many cases of coagulation factor concentrates transmitted viral disease clearly demonstrated the need to establish standardized measures to render plasma products pathogen safe. In the second half of the 1990s, authorities shifted regulatory 作者: Urologist 時間: 2025-3-24 21:31 作者: 驚惶 時間: 2025-3-25 00:53 作者: vibrant 時間: 2025-3-25 07:11 作者: output 時間: 2025-3-25 11:32
Kapitel 7: Erfassung sozialer Ph?nomeneluded effects mediated through the Fab region of IgG, while others have been through the Fc region of IVIg. The presence of sugars or glycans on the Fc region have been considered by some to be important, while other work has pointed to a major role for IgG dimers or immune complexes as mediating IV作者: aspersion 時間: 2025-3-25 13:20 作者: Misgiving 時間: 2025-3-25 17:53 作者: VICT 時間: 2025-3-25 21:47
Politische Institutionen (Polity)sion by IgG concentrates in the early 1990s together with many cases of coagulation factor concentrates transmitted viral disease clearly demonstrated the need to establish standardized measures to render plasma products pathogen safe. In the second half of the 1990s, authorities shifted regulatory 作者: vertebrate 時間: 2025-3-26 02:34 作者: choroid 時間: 2025-3-26 07:54 作者: BUDGE 時間: 2025-3-26 12:00
Kapitel 6: Grundbegriffe und Datenerhebungtreatment is off-label for most dermatological indications. The most current guidelines on the use of IVIg in dermatology were provided by the European Dermatology Forum in 2016 (Enk et al. 2016). Other comprehensive guidelines on the use of IVIg exist for the United Kingdom (Provan et al. 2008) and Australia (Group NICRW 2012).作者: Bureaucracy 時間: 2025-3-26 12:47
Immunomodulatory Drugs and Monoclonal Antibodieshways, immune cellular trafficking, and signaling molecules such as chemokines and cytokines. In particular, monoclonal antibodies that inhibit cytokine or cytokine receptors have become important immune-modulating agents in autoimmune disease.作者: Mutter 時間: 2025-3-26 19:06 作者: 半球 時間: 2025-3-26 22:31 作者: 殘廢的火焰 時間: 2025-3-27 03:04
ate on immunomodulatory IgG treatment in ITP.Examines mAbs aThis practical manual, written by well-known experts, reviews current indications for the use of IgG concentrates and some other modern immunomodulators and provides fundamental information on present-day immunomodulation in patients (and m作者: Restenosis 時間: 2025-3-27 08:35 作者: 看法等 時間: 2025-3-27 09:37 作者: 嚴(yán)重傷害 時間: 2025-3-27 16:36 作者: 落葉劑 時間: 2025-3-27 19:54 作者: 加劇 時間: 2025-3-28 01:23 作者: Exhilarate 時間: 2025-3-28 04:45 作者: 首創(chuàng)精神 時間: 2025-3-28 07:19
Current IgG Products and Future Perspectivesin preclinical or clinical development/evaluation. IG in combination with monoclonal antibodies such as signaling pathway inhibitors or engineered T-cell regulators are becoming options for more potent immunomodulation in inflammatory or autoimmune disorders.作者: 奇怪 時間: 2025-3-28 12:04 作者: 提名 時間: 2025-3-28 14:53
Einführung in die theoretische Gasdynamikin practical clinical science. Substitutive administration of a new concentrate of a human immunoglobulin (IgG) preparation resulted in regular minimal platelet increases in a child with a primary immunodeficiency and low platelet counts despite normal platelet production. The investigators conclude作者: Glaci冰 時間: 2025-3-28 22:41
Einführung in die theoretische Gasdynamikestones in the history of human immunoglobulins since the initial observation by Ogden C. Bruton who described replacement therapy in a single boy with agammaglobulinemia. Since then, the preparations used for treatment have been markedly improved with respect to tolerability, clinical efficacy, and作者: excursion 時間: 2025-3-28 23:11 作者: 重力 時間: 2025-3-29 04:24
Kapitel 7: Erfassung sozialer Ph?nomeneoimmune syndromes. Although the precise mechanism of action of IVIg as an immunomodulatory agent has been elusive, many theories over the years have been postulated. These theories include mononuclear phagocytic system blockade, autoantibody neutralization, increased clearance of pathogenic autoanti作者: RENIN 時間: 2025-3-29 08:53 作者: 整潔漂亮 時間: 2025-3-29 15:11
Kapitel 10: Theorien der Gegenwartously untreatable, or poorly managed, conditions. Based on controlled trials, IVIg is approved as first-line therapy for patients with GBS, CIDP, and multifocal motor neuropathy. In CIDP, where the largest controlled study was performed, IVIg is also effective in the chronic management of the diseas作者: Hippocampus 時間: 2025-3-29 18:47
Kapitel 6: Grundbegriffe und Datenerhebungwhen Furusho et al. (1984) and Newburger et al. (1986), respectively, reported the successful application of IVIg in Kawasaki syndrome. Seven years later, Dalakas et al. (1993) reported the first successful randomized controlled trial of IVIg in the treatment of dermatomyositis. Ever since, IVIg has作者: 業(yè)余愛好者 時間: 2025-3-29 23:13 作者: 季雨 時間: 2025-3-30 02:25 作者: 離開可分裂 時間: 2025-3-30 04:39 作者: anaphylaxis 時間: 2025-3-30 11:15 作者: Anal-Canal 時間: 2025-3-30 15:54
,Erleben und Verhalten in R?umen,that requires ongoing treatment. At presentation, it is not possible to differentiate between the patients who will have a short duration of thrombocytopenia from those who will develop chronic disease. Predictors of ITP outcome would help guide treatment decisions and ultimately improve quality of 作者: 縱欲 時間: 2025-3-30 19:22
https://doi.org/10.1007/978-3-662-01484-4Please check the hierarchy of the section headings and correct if necessary.作者: 我吃花盤旋 時間: 2025-3-30 21:15
Einführung in die theoretische PhilosophieThis manual is a brief summary of extensive reviews of the literature extracted from PubMed and a recent review by Perez et al. (2017), which mainly categorizes the indications according to FDA/EMA approvals and evidence-based findings.作者: 鞭子 時間: 2025-3-31 01:55 作者: 閑蕩 時間: 2025-3-31 08:36 作者: constitute 時間: 2025-3-31 11:51 作者: 集合 時間: 2025-3-31 16:01
